Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iovance Biotherapeutics Inc 825 INDUSTRIAL ROAD SUITE 400 SAN CARLOS CA 94070 USA

www.iovance.com P: 650-260-7120

Description:

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own immune system to eradicate cancer cells.

Key Statistics

Overview:

Market Capitalization, $K 3,270,685
Enterprise Value, $K 3,156,795
Shares Outstanding, K 279,307
Annual Sales, $ 1,190 K
Annual Net Income, $ -444,040 K
Last Quarter Sales, $ 480 K
Last Quarter Net Income, $ -116,380 K
EBIT, $ -460,570 K
EBITDA, $ -431,050 K
60-Month Beta 0.62
% of Insider Shareholders 10.40%
% of Institutional Shareholders 77.03%
Float, K 250,259
% Float 89.60%
Short Volume Ratio 0.40

Growth:

1-Year Return 109.44%
3-Year Return -63.30%
5-Year Return 1.32%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -48.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 02/28/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.88
EPS Growth vs. Prev Qtr 2.17%
EPS Growth vs. Prev Year 29.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 09/27/13

IOVA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.93%
Return-on-Assets % -55.25%
Profit Margin % -37,314.28%
Debt/Equity 0.00
Price/Sales 2,786.02
Price/Cash Flow N/A
Price/Book 4.96
Book Value/Share 2.28
Interest Coverage -3.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar